Form 4: Dolby Director Tevanian Awarded 3,908 RSUs

Dolby Laboratories Director Avadis Tevanian received an award of 3,908 restricted stock units as part of his compensation.

Summary

• Avadis Tevanian, a Director of Dolby Laboratories, Inc. (DLB), was granted 3,908 restricted stock units (RSUs).
• The RSUs were awarded under the terms of the Issuer's 2020 Stock Plan.
• Each RSU represents a contingent right to receive one share of Dolby's Class A Common Stock upon vesting.
• Vesting will occur on the earlier of (i) the first anniversary of the grant date (February 3, 2027) or (ii) the date immediately preceding Dolby's 2027 annual meeting of stockholders.
• Vesting is conditional on Mr. Tevanian continuing to serve as a member of the board of directors on the vesting date.
• Following this transaction, Mr. Tevanian directly holds 3,908 shares of Class A common stock underlying RSUs (subject to forfeiture) and indirectly holds 62,670 shares of Class A Common Stock through the Avadis Tevanian Jr. and Nancy Tevanian Trust u/a/d May 29 1996.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive event, reflecting standard corporate governance practices where director compensation is aligned with shareholder interests through equity awards, without indicating any significant operational or financial changes.

Positives

• The grant of restricted stock units aligns the director's interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
• This is a routine compensation event for a director, indicating ongoing board engagement and stability.

Negatives

• No specific negative aspects are detailed in this Form 4 filing, which primarily reports an insider transaction.

Risks

• The 3,908 restricted stock units are subject to forfeiture if the reporting person does not continue to serve as a member of the Issuer's board of directors until the vesting date.

Future Outlook

The restricted stock units are expected to vest on the earlier of the first anniversary of the grant date or the date immediately preceding the Issuer's 2027 annual meeting of stockholders, contingent on the director's continued service.

Management Comments

• The filing was signed by Daniel Rodriguez as Attorney-in-Fact for Avadis Tevanian.

Industry Context

StockSavvy.ai notes that grants of restricted stock units to non-employee directors are a common practice across various industries, including technology and media, serving as a key component of director compensation to align their long-term interests with those of shareholders.

Comparison to Industry Standards

• The grant of RSUs as director compensation is a standard practice, comparable to compensation structures seen at companies like Apple Inc. (AAPL) or Microsoft Corp. (MSFT) for their non-executive directors, where equity awards form a significant portion of their remuneration.
• The vesting schedule, tied to continued board service, is typical for such awards, ensuring retention and commitment from board members.

Corporate Governance

Related Party Transactions

• Avadis Tevanian Jr. and Nancy Tevanian Trust u/a/d May 29 1996 indirectly holds 62,670 shares of Class A Common Stock, indicating a related party holding.

Stakeholder Impact

• Shareholders: The grant of RSUs to a director helps align the director's long-term interests with those of shareholders, potentially fostering better governance and strategic decisions.
• Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

• The restricted stock units will vest on the earlier of February 3, 2027, or the date immediately preceding the Issuer's 2027 annual meeting of stockholders, provided the director remains on the board.

Key Dates

Keywords

Dolby Laboratories, DLB, Restricted Stock Units, RSU, Insider Transaction, Director Compensation, SEC Form 4, Stock Plan, Corporate Governance